These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 22430357)

  • 1. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions.
    Chakraborty S; Chakravorty R; Ahmed M; Rahman A; Waise TM; Hassan F; Rahman M; Shamsuzzaman S
    In Silico Biol; 2010; 10(5-6):235-46. PubMed ID: 22430357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel immunization approach for dengue infection based on conserved T cell epitopes formulated in calcium phosphate nanoparticles.
    Huang X; Karabudak A; Comber JD; Philip M; Morcol T; Philip R
    Hum Vaccin Immunother; 2017 Nov; 13(11):2612-2625. PubMed ID: 28933657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatics and molecular docking studies reveal potential epitope-based peptide vaccine against DENV-NS3 protein.
    Tahir RA; Wu H; Rizwan MA; Jafar TH; Saleem S; Sehgal SA
    J Theor Biol; 2018 Dec; 459():162-170. PubMed ID: 30291844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring dengue proteome to design an effective epitope-based vaccine against dengue virus.
    Sabetian S; Nezafat N; Dorosti H; Zarei M; Ghasemi Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2546-2563. PubMed ID: 30035699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
    Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
    J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design.
    Hussain M; Idrees M; Afzal S
    Curr Comput Aided Drug Des; 2015; 11(1):84-97. PubMed ID: 26022067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.
    Shi J; Sun J; Wu M; Hu N; Li J; Li Y; Wang H; Hu Y
    PLoS One; 2015; 10(9):e0138729. PubMed ID: 26381649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection.
    Ali M; Pandey RK; Khatoon N; Narula A; Mishra A; Prajapati VK
    Sci Rep; 2017 Aug; 7(1):9232. PubMed ID: 28835708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein.
    Tian J; Zeng G; Pang X; Liang M; Zhou J; Fang D; Liu Y; Li D; Jiang L
    Int Immunol; 2012 Apr; 24(4):207-18. PubMed ID: 22298881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational elucidation of potential antigenic CTL epitopes in Ebola virus.
    Dikhit MR; Kumar S; Vijaymahantesh ; Sahoo BR; Mansuri R; Amit A; Yousuf Ansari M; Sahoo GC; Bimal S; Das P
    Infect Genet Evol; 2015 Dec; 36():369-375. PubMed ID: 26462623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic B-Cell Epitopes Eliciting Cross-Neutralizing Antibodies: Strategies for Future Dengue Vaccine.
    Ramanathan B; Poh CL; Kirk K; McBride WJ; Aaskov J; Grollo L
    PLoS One; 2016; 11(5):e0155900. PubMed ID: 27223692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.
    Sánchez-Burgos G; Ramos-Castañeda J; Cedillo-Rivera R; Dumonteil E
    Virus Res; 2010 Oct; 153(1):113-20. PubMed ID: 20638434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic peptides containing B- and T-cell epitope of dengue virus-2 E domain III provoked B- and T-cell responses.
    Li S; Peng L; Zhao W; Zhong H; Zhang F; Yan Z; Cao H
    Vaccine; 2011 May; 29(20):3695-702. PubMed ID: 21419774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
    Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
    Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of conserved and HLA-A*2402-restricted epitopes in Dengue virus serotype 2.
    Duan ZL; Liu HF; Huang X; Wang SN; Yang JL; Chen XY; Li DZ; Zhong XZ; Chen BK; Wen JS
    Virus Res; 2015 Jan; 196():5-12. PubMed ID: 25449574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.
    Khanam S; Pilankatta R; Khanna N; Swaminathan S
    Vaccine; 2009 Oct; 27(43):6011-21. PubMed ID: 19665609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
    Livingston PG; Kurane I; Dai LC; Okamoto Y; Lai CJ; Men R; Karaki S; Takiguchi M; Ennis FA
    J Immunol; 1995 Feb; 154(3):1287-95. PubMed ID: 7529799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.
    Roth C; Cantaert T; Colas C; Prot M; Casadémont I; Levillayer L; Thalmensi J; Langlade-Demoyen P; Gerke C; Bahl K; Ciaramella G; Simon-Loriere E; Sakuntabhai A
    Front Immunol; 2019; 10():1424. PubMed ID: 31293584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.